Frontiers in Cardiovascular Medicine

MARCH 25, 2025

Cardio-cerebral infarction (CCI) is a rare clinical syndrome characterized by the simultaneous or sequential occurrence of acute myocardial infarction (AMI) and acute ischemic stroke (AIS).

Myocardial Infarction 52

Myocardial Infarction Article Research Patient Care 52

American College of Cardiology

APRIL 7, 2024

The goal of the REDUCE-AMI trial was to evaluate the potential benefit of beta-blockade following acute myocardial infarction (AMI) in patients with preserved left ventricular ejection fraction (LVEF) in the modern era of coronary revascularization and medical therapy.

Myocardial Infarction 65

Myocardial Infarction Article 65

American College of Cardiology

FEBRUARY 12, 2024

The MULTISTARS AMI (MULTivessel Immediate versus STAged RevaScularization in Acute Myocardial Infarction) trial compared immediate versus delayed percutaneous coronary intervention (PCI) of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) who underwent successful primary PCI of the culprit lesion.

Myocardial Infarction 61

Myocardial Infarction STEMI Article 61

American College of Cardiology

JANUARY 23, 2024

Both the COMPLETE and PRAMI trial findings supported the benefits of complete revascularization over culprit-only percutaneous coronary intervention (PCI) in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease.

Myocardial Infarction 69

Myocardial Infarction Coronary Artery Disease Article 69

Frontiers in Cardiovascular Medicine

MARCH 10, 2024

Background Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). Methods We conducted a comprehensive search for articles on PubMed and Embase using search strategies which yielded 4,061 articles.

Myocardial Infarction 59

Myocardial Infarction Cardiogenic Shock Article STEMI 59

American College of Cardiology

NOVEMBER 7, 2024

The goal of the PACMAN-AMI trial was to demonstrate the efficacy of early administration of alirocumab on plaque characteristics among patients undergoing percutaneous coronary intervention (PCI) for an acute myocardial infarction (AMI).

Myocardial Infarction 58

Myocardial Infarction Atherosclerosis Plaque Article 58

American College of Cardiology

MARCH 4, 2024

The goal of the TALOS-AMI trial was to assess whether de-escalating dual antiplatelet therapy (DAPT) with clopidogrel rather than ticagrelor 1 month after percutaneous coronary intervention (PCI) for an acute myocardial infarction (AMI) would be a noninferior strategy.

Myocardial Infarction 58

Myocardial Infarction Article 58

American College of Cardiology

APRIL 6, 2024

The goal of the EMPACT-MI trial was to determine whether adding the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin to the treatment of acute myocardial infarction (AMI) affects future mortality or heart failure (HF) in at-risk patients.

Myocardial Infarction 65

Myocardial Infarction Heart Failure Hospital Article 65

American College of Cardiology

DECEMBER 2, 2024

Current guidelines regarding beta-blocker use after myocardial infarction (MI) recommend against continuation to improve outcomes after 1 year, in the absence of reduced left ventricular ejection fraction (LVEF; <50%) or other primary indications for therapy.

Myocardial Infarction 49

Myocardial Infarction Outcomes Article 49

American College of Cardiology

SEPTEMBER 13, 2024

The goal of the ECLS-SHOCK trial was to evaluate extracorporeal life support (ECLS) compared with control among patients with acute myocardial infarction (MI) and cardiogenic shock.

Cardiogenic Shock 46

Cardiogenic Shock Myocardial Infarction Article 46

Open Heart

JANUARY 29, 2024

Objectives This study aimed to perform a meta-analysis of the short-term impact of ischaemic postconditioning (IPoC) on myocardial injury in ST elevation myocardial infarction (STEMI) using surrogate cardiac biomarkers. Methods Eligible studies were identified using several article databases.

Myocardial Infarction 52

Myocardial Infarction STEMI Article Biomarkers 52

American College of Cardiology

AUGUST 30, 2024

The goal of the ABYSS trial was to evaluate beta-blocker interruption compared with beta-blocker continuation after an uncomplicated myocardial infarction (MI).

Myocardial Infarction 52

Myocardial Infarction Hospital Article 52

American College of Cardiology

SEPTEMBER 1, 2024

The goal of the SENIOR-RITA trial was to evaluate routine invasive therapy compared with conservative therapy among older patients with non–ST-elevation myocardial infarction (NSTEMI).

Myocardial Infarction 43

Myocardial Infarction Article 43

Circulation

JANUARY 12, 2025

Circulation, Volume 151, Issue 2 , Page e22-e22, January 14, 2025.

Myocardial Infarction 49

Myocardial Infarction Article Circulation 49

Circulation

JANUARY 12, 2025

Circulation, Volume 151, Issue 2 , Page e23-e23, January 14, 2025.

Myocardial Infarction 49

Myocardial Infarction Article Circulation 49

Journal of Cardiovascular Pharmacology

OCTOBER 24, 2024

Myocardial remodeling is characterized by gradual heart enlargement, cardiac dysfunction, and extraordinary molecular changes. Cardiac remodeling after myocardial infarction is almost inevitable, which is the leading cause of heart failure. Autophagy has a protective effect on myocardial remodeling improvement.

Myocardial Infarction 40

Myocardial Infarction Ischemia Heart Failure Heart Disease 40

Nature Reviews - Cardiology

MAY 6, 2024

Nature Reviews Cardiology, Published online: 07 May 2024; doi:10.1038/s41569-024-01014-0 In 1993, Lincoff and Topol claimed that the thrombolytic treatment of ST-segment elevation myocardial infarction was suboptimal in many patients and gave an ‘illusion of reperfusion’.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Article Outcomes 64

Circulation

JANUARY 7, 2024

Circulation, Volume 149, Issue 2 , Page 167-167, January 9, 2024.

Myocardial Infarction 45

Myocardial Infarction Article Circulation 45

American College of Cardiology

APRIL 7, 2025

Chronic inflammation plays a role in the pathogenesis of cardiovascular diseases, including atherosclerosis, pericarditis, stroke, and myocardial infarction (MI).

Atherosclerosis 74

Atherosclerosis Myocardial Infarction Pericarditis Cardiovascular Disease 74

Circulation

MARCH 17, 2024

Circulation, Volume 149, Issue 12 , Page e962-e963, March 19, 2024.

Myocardial Infarction 49

Myocardial Infarction Article Circulation 49

European Journal of Heart Failure

JANUARY 14, 2025

The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.

Myocardial Infarction 40

Myocardial Infarction Bicuspid/Mitral Cardiogenic Shock Risk Factors 40

Dr. Smith's ECG Blog

JULY 31, 2020

The article by Aslanger, Smith et al that is featured above in today’s post has just been published. The above-cited newly published article by Aslanger, Smith et al provides further support to the growing body of literature of why we should compel ourselves to do so. P.S.: Our September 3, 2020 post features Dr.

STEMI 52

STEMI Article Chest Pain Blog 52

European Journal of Heart Failure

DECEMBER 13, 2023

Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenic shock (AMICS). Methods and results This nationwide observational cohort study describes all AMICS patients treated with Impella (ABIOMED, Danvers, MA, USA) and/or VA-ECMO in 2020–2021.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Hospital 40

American College of Cardiology

MARCH 24, 2025

Among individuals without significant cardiovascular morbidity younger than 50 years, the use of cannabis is linked to adverse cardiovascular events, including a sixfold higher risk of a myocardial infarction (MI), fourfold increase risk of ischemic stroke.

Heart Attack 74

Heart Attack Heart attacks Myocardial Infarction Stroke 74

Dr. Smith's ECG Blog

SEPTEMBER 26, 2023

See these 2 articles Association between pre-hospital chest pain severity and myocardial injury in ST elevation myocardial infarction: A post-hoc analysis of the AVOID study Author links open overlay panel [link] 1 Background We sought to determine if an association exists between prehospital chest pain severity and markers of myocardial injury.

Chest Pain 118

Chest Pain STEMI Myocardial Infarction Electrocardiogram 118

Nature Reviews - Cardiology

JUNE 18, 2024

Nature Reviews Cardiology, Published online: 19 June 2024; doi:10.1038/s41569-024-01055-5 In this Tools of the Trade article, Berkeley and Thomson describe the use of a minimally invasive strategy to standardize the induction of myocardial infarction in mice.

Myocardial Infarction 52

Myocardial Infarction Article 52

Circulation

JANUARY 7, 2024

Circulation, Volume 149, Issue 2 , Page 168-169, January 9, 2024.

Myocardial Infarction 45

Myocardial Infarction Article Circulation 45

American College of Cardiology

JULY 23, 2024

What is the impact of procedural myocardial infarction (pMI) and spontaneous myocardial infarction (spMI) across different levels of troponin elevation on mortality among patients undergoing percutaneous coronary intervention (PCI)?

Myocardial Infarction 69

Myocardial Infarction Article 69

Journal of Cardiovascular Pharmacology

SEPTEMBER 5, 2024

This article is available as a PDF only. An abstract is unavailable.

Myocardial Infarction 40

Myocardial Infarction Article 40

Journal of Cardiovascular Pharmacology

JULY 18, 2024

This article is available as a PDF only. An abstract is unavailable.

Myocardial Infarction 40

Myocardial Infarction Article Outcomes 40

American College of Cardiology

MARCH 29, 2025

Rivaroxaban was found to be as effective and safe as warfarin in resolving post myocardial infarction (MI) left ventricular (LV) thrombus at three months, according to a Late-Breaking Clinical Trial presented at ACC.25 25 in Chicago.

Myocardial Infarction 73

Myocardial Infarction Article 73

American College of Cardiology

NOVEMBER 7, 2024

What is the impact of complete revascularization versus culprit-only revascularization on outcomes in older patients with ST-segment elevation myocardial infarction (STEMI) and non–ST-segment elevation myocardial infarction (NSTEMI)?

STEMI 67

STEMI Myocardial Infarction Outcomes Article 67

Dr. Smith's ECG Blog

OCTOBER 8, 2024

HYPERACUTE T-WAVES ARE EASILY RECOGNIZED BY THE QUEEN OF HEARTS HYPERACUTE T-WAVES DO NOT EVOLVE INTO ST ELEVATION -- THIS IS A MYTH Pendell and I are about to submit an article on ECG findings in total 100% LAD Occlusion (LAD OMI). Hyperacute T Wave in the Early Diagnosis of Acute Myocardial Infarction. 2023;82:194–202.

Cardiac Arrest 122

Cardiac Arrest Myocardial Infarction STEMI Cardiogenic Shock 122

European Journal of Heart Failure

OCTOBER 30, 2023

CMR, cardiac magnetic resonance; LV, left ventricular; LVEDVi, left ventricular end-diastolic volume index; LVEF, left ventricular ejection fraction; LVESVi, left ventricular end-systolic volume index; MI, myocardial infarction; pPCI, primary percutaneous coronary intervention; SE, standard error; STEMI, ST-elevation myocardial infarction.

Myocardial Infarction 40

Myocardial Infarction STEMI Angioplasty Research 40

American College of Cardiology

MAY 23, 2024

What is the prognostic significance of various microvascular injury (MVI) patterns after ST-segment elevation myocardial infarction (STEMI)?

STEMI 73

STEMI Myocardial Infarction Article 73

American College of Cardiology

SEPTEMBER 10, 2024

Is early cardiac magnetic resonance (CMR) prior to an invasive coronary angiogram (ICA) in patients with suspected non–ST-segment elevation myocardial infarction (NSTEMI) useful?

Coronary Angiogram 73

Coronary Angiogram Myocardial Infarction Article 73

American College of Cardiology

MAY 3, 2024

The following are key points to remember from a JACC Focus Seminar, which presents an in-depth, contemporary understanding of the pathophysiology, clinical consequences, and management of right ventricular (RV) myocardial infarction (MI).

Myocardial Infarction 75

Myocardial Infarction Article 75